Trial intelligence / Profile preview

Pediatric comparison of rocuronium duration at the abductor digiti minimi versus adductor pollicis

jRCT1030260468Recruiting

Start
Sep 2026
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of rocuronium, sponsored by none. Primary endpoint: Duration of occurrence where the TOF count is 1. Started Sep 2026; status: recruiting.

02

Drugs

rocuronium

Beyond the preview

Go deeper on jRCT1030260468.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT1030260468.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call